Technology | June 26, 2015

Cheetah Medical Introduces Starling SV Noninvasive Hemodynamic Monitoring System

System predicts IV-fluids responsiveness similarly to esophageal Doppler and other invasive modalities

Cheetah Medical, Starling SV, hemodynamic monitoring system, noninvasive

June 26, 2015 - Cheetah Medical announced that it is now offering the U.S. Food and Drug Administration (FDA)-cleared and CE-marked Starling SV hemodynamic monitoring system. The noninvasive system provides data for real-time clinical decision-making and optimized patient outcomes across a hospital's continuum of care.

Dynamic IV fluid-assessment using the Starling SV and the benchmark Cheetah NICOM systems allow noninvasive, real-time knowledge of whether a patient will be helped or potentially harmed by additional IV fluids.

The expansion of Cheetah medical's product line comes on the heels of results in three major clinical trials (ProCESS, ProMISE, ARISE), as well as updated sepsis guidelines from several organizations - all of whom updated their guidance to include dynamic measures of fluid responsiveness for patients with severe sepsis or septic shock.

IV-fluid responsiveness is also a major component of Enhanced Recovery After Surgery (ERAS), which is showing improved clinical outcomes for surgical patients.

The Starling SV system has a sensitivity of 94 percent and specificity of 100 percent for predicting IV-fluids responsiveness in critical care situations. The system predicts IV-fluids responsiveness similarly to invasive esophageal Doppler and other invasive modalities. In addition to predicting fluid responsiveness, it is one of the few technologies that allows clinicians to directly monitor the change in cardiac stroke volume with therapy. Starling SV may assist in reducing hospital length of stay (LOS).

Other benefits of the system include:

  • Eliminates risk of infection and vascular damage associated with older, invasive technologies requiring arterial or central lines;
  • Independently validated against pulmonary artery catheter;
  • Accuracy not affected by vasopressors, inotropes, and shock states;
  • Nurse-driven;
  • Electronic medical record (EMR)-compatible, with the ability to establish a time-stamped patient record for documentation; and
  • Provides continuous information on cardiac index, cardiac output, stroke volume index, stroke volume, total peripheral resistance and other parameters.


For more information:

Related Content

Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems | September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Merge Hemo cath lab hemodynamics monitoring system.

Hemodynamic data shown on screens from the Merge Hemo recording system. It is among the newer generation hemodynamic systems for cath labs that are more user friendly and have technologies to speed workflow.

Feature | Hemodynamic Monitoring Systems | August 03, 2017 | Dave Fornell
The current generation of...
Siemens, Sensis Vibe hemodynamic system, ACC 2016
Technology | Hemodynamic Monitoring Systems | April 01, 2016
Siemens will unveil a revamped version of its established Sensis hemodynamic system at the 65 th Annual Scientific...
Feature | Hemodynamic Monitoring Systems | January 12, 2016 | Dave Fornell
Beyond measuring blood flow, pressure, oxygen levels and other vital signs in the cardiac catheterization lab, curren
Overlay Init